688 related articles for article (PubMed ID: 28868790)
1. Insulin regulation of gluconeogenesis.
Hatting M; Tavares CDJ; Sharabi K; Rines AK; Puigserver P
Ann N Y Acad Sci; 2018 Jan; 1411(1):21-35. PubMed ID: 28868790
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulators of hepatic gluconeogenesis.
Oh KJ; Han HS; Kim MJ; Koo SH
Arch Pharm Res; 2013 Feb; 36(2):189-200. PubMed ID: 23361586
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathophysiology of hepatic glucose production.
Sharabi K; Tavares CD; Rines AK; Puigserver P
Mol Aspects Med; 2015 Dec; 46():21-33. PubMed ID: 26549348
[TBL] [Abstract][Full Text] [Related]
4. Splanchnic regulation of glucose production.
Wahren J; Ekberg K
Annu Rev Nutr; 2007; 27():329-45. PubMed ID: 17465853
[TBL] [Abstract][Full Text] [Related]
5. Regulation of hepatic glucose metabolism in health and disease.
Petersen MC; Vatner DF; Shulman GI
Nat Rev Endocrinol; 2017 Oct; 13(10):572-587. PubMed ID: 28731034
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
[TBL] [Abstract][Full Text] [Related]
7. Silencing of FGF-21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT3-SOCS3 signal.
Wang C; Dai J; Yang M; Deng G; Xu S; Jia Y; Boden G; Ma ZA; Yang G; Li L
FEBS J; 2014 May; 281(9):2136-47. PubMed ID: 24593051
[TBL] [Abstract][Full Text] [Related]
8. CREBH Maintains Circadian Glucose Homeostasis by Regulating Hepatic Glycogenolysis and Gluconeogenesis.
Kim H; Zheng Z; Walker PD; Kapatos G; Zhang K
Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28461393
[TBL] [Abstract][Full Text] [Related]
9. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis.
Basu R; Chandramouli V; Dicke B; Landau B; Rizza R
Diabetes; 2005 Jul; 54(7):1942-8. PubMed ID: 15983193
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hepatic glucose metabolism via gluconeogenesis and glycogenolysis after oral administration of insulin nanoparticles.
Woitiski CB; Neufeld RJ; Soares AF; Figueiredo IV; Veiga FJ; Carvalho RA
Drug Dev Ind Pharm; 2012 Dec; 38(12):1441-50. PubMed ID: 22324290
[TBL] [Abstract][Full Text] [Related]
11. Contributions of hepatic gluconeogenesis suppression and compensative glycogenolysis on the glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, in non-obese type 2 diabetes Goto-Kakizaki rats.
Yoshida T; Okuno A; Takahashi K; Ogawa J; Hagisawa Y; Kanda S; Fujiwara T
J Pharmacol Sci; 2011; 115(3):329-35. PubMed ID: 21350313
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
[TBL] [Abstract][Full Text] [Related]
13. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms.
Wiernsperger NF; Bailey CJ
Drugs; 1999; 58 Suppl 1():31-9; discussion 75-82. PubMed ID: 10576523
[TBL] [Abstract][Full Text] [Related]
14. Regulation of hepatic glucose production in healthy subjects and patients with non-insulin-dependent diabetes mellitus.
Tappy L
Diabete Metab; 1995 Oct; 21(4):233-40. PubMed ID: 8529757
[TBL] [Abstract][Full Text] [Related]
15. Ferulic acid exerts its antidiabetic effect by modulating insulin-signalling molecules in the liver of high-fat diet and fructose-induced type-2 diabetic adult male rat.
Narasimhan A; Chinnaiyan M; Karundevi B
Appl Physiol Nutr Metab; 2015 Aug; 40(8):769-81. PubMed ID: 26201855
[TBL] [Abstract][Full Text] [Related]
16. Novel concepts in insulin regulation of hepatic gluconeogenesis.
Barthel A; Schmoll D
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E685-92. PubMed ID: 12959935
[TBL] [Abstract][Full Text] [Related]
17. Control of glycaemia.
Gerich JE
Baillieres Clin Endocrinol Metab; 1993 Jul; 7(3):551-86. PubMed ID: 8379904
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Effects of Metformin in Humans.
Adeva-Andany MM; Rañal-Muíño E; Fernández-Fernández C; Pazos-García C; Vila-Altesor M
Curr Diabetes Rev; 2019; 15(4):328-339. PubMed ID: 30306875
[TBL] [Abstract][Full Text] [Related]
19. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
20. T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis.
Fukushima A; Loh K; Galic S; Fam B; Shields B; Wiede F; Tremblay ML; Watt MJ; Andrikopoulos S; Tiganis T
Diabetes; 2010 Aug; 59(8):1906-14. PubMed ID: 20484139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
